Loading...
Loading...
Contributors:
Dataset URI:
52f38a42-3b3e-4a84-8d2b-42002d221e0eThe purpose of this clinical trial is to demonstrate the benefit of the immunotherapeutic product GSK1572932A when given to patients with Non-Small Cell Lung Cancer, after removal of their tumor. A course of 13 injections will be administered over 27 months. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Keyword(s):
GSK1572932A; GSK1572932A Antigen-Specific Cancer Immunotherapeutic; Lung Cancer, Non-Small Cell; Non-small Cell Lung Cancer; Oncology.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)